These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12595506)

  • 1. The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy.
    Awazu M; Omori S; Ishikura K; Hida M; Fujita H
    J Am Soc Nephrol; 2003 Mar; 14(3):699-708. PubMed ID: 12595506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
    Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
    Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells.
    Wolf G; Reinking R; Zahner G; Stahl RA; Shankland SJ
    Diabetologia; 2003 Aug; 46(8):1090-9. PubMed ID: 12856081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
    Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
    Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia.
    Wolf G; Schroeder R; Thaiss F; Ziyadeh FN; Helmchen U; Stahl RA
    Kidney Int; 1998 Apr; 53(4):869-79. PubMed ID: 9551393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
    Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
    Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
    Kim SI; Han DC; Lee HB
    J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of type VIII collagen in mice ameliorates diabetic nephropathy.
    Hopfer U; Hopfer H; Meyer-Schwesinger C; Loeffler I; Fukai N; Olsen BR; Stahl RA; Wolf G
    Diabetes; 2009 Jul; 58(7):1672-81. PubMed ID: 19401424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
    Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
    J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulation in diabetic nephropathy.
    Wolf G
    Kidney Int Suppl; 2000 Sep; 77():S59-66. PubMed ID: 10997692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
    Brizzi MF; Dentelli P; Rosso A; Calvi C; Gambino R; Cassader M; Salvidio G; Deferrari G; Camussi G; Pegoraro L; Pagano G; Cavallo-Perin P
    FASEB J; 2004 Aug; 18(11):1249-51. PubMed ID: 15180953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.
    Wolf G; Schroeder R; Zahner G; Stahl RA; Shankland SJ
    Am J Pathol; 2001 Mar; 158(3):1091-100. PubMed ID: 11238057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
    J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.
    Nasrallah R; Hébert RL
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F673-81. PubMed ID: 15161601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.